GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Apogee Therapeutics
The shares of Apogee, a biotech company specializing in the treatment of inflammatory diseases, reflect the potential of its long-acting drugs. The price chart is a classic biotech story, with the price determined by expectations of clinical trial results.
Share prices of companies in the market segment - Pharma skin
Apogee is a biotech company specializing in developing drugs for the treatment of inflammatory and immunological diseases. We classify it in the Pharma Skin sector, and the chart below shows the general performance of biotech companies, where valuation is determined by clinical trial results.
Broad Market Index - GURU.Markets
Apogee Therapeutics is a biopharmaceutical company developing antibody-based therapies for the treatment of inflammatory and immunological diseases. Its innovative approach makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Apogee compares to it.
Change in the price of a company, segment, and market as a whole per day
APGE - Daily change in the company's share price Apogee Therapeutics
Shares of Apogee Therapeutics, a biotech company developing drugs to treat inflammatory diseases, are highly volatile. Change_co measures the market's reaction to clinical trial data. This metric is an important component of formulas on System.GURU.Markets that evaluate innovative companies in the immunology sector.
Daily change in the price of a set of shares in a market segment - Pharma skin
Apogee Therapeutics, Inc. is a biotech company. This chart highlights the extreme volatility of the sector. Comparing it to APGE's performance, which is dependent on clinical trial results, helps assess it as a high-risk asset compared to more diversified companies.
Daily change in the price of a broad market stock, index - GURU.Markets
Apogee Therapeutics is a biopharmaceutical company specializing in drugs for the treatment of inflammatory diseases. Immunology is a cutting-edge but highly volatile segment of biotechnology. The chart below shows average daily fluctuations in this area, allowing you to assess the performance of Apogee's stock.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Apogee Therapeutics
Apogee is a biotech company focused on immunology. Its shares, like many in the sector, are highly volatile and react to news about clinical trials. These science-driven movements are part of the complex and diverse landscape of the entire stock market.
Annual dynamics of market capitalization of the market segment - Pharma skin
Apogee Therapeutics is a biotech company developing innovative drugs for the treatment of inflammatory diseases. Its stock performance is entirely dependent on clinical trial results. The chart reflects the high risks and potential for breakthroughs typical of the biotech sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Apogee Therapeutics is a clinical-stage biotech whose fate depends on scientific breakthroughs, not the state of the economy. Its stock price reflects investor hopes for the success of new drug trials. The company's chart exists in a world of its own, where the main events are data releases.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Apogee Therapeutics
Apogee, a clinical-stage biopharmaceutical company specializing in inflammatory and immunological diseases, has sharp monthly fluctuations reflecting the release of clinical trial data, which is key to its valuation.
Monthly dynamics of market capitalization of the market segment - Pharma skin
The immunology-focused biotech sector is buzzing with anticipation of clinical breakthroughs. Its market capitalization, shown in the chart, reflects investor faith in new treatments for complex diseases. In this environment, full of risk and hope, companies like Apogee Therapeutics are pursuing their expensive research.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Apogee Therapeutics is an early-stage biotech focused on immunology. Its stock moves not in sync with the market, but rather on news about clinical trials. Any success or failure causes sharp fluctuations, defying overall trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Apogee Therapeutics
Apogee Therapeutics is a clinical-stage biotech company focused on developing drugs for the treatment of inflammatory and immunological diseases, such as skin diseases. Its weekly performance is extremely volatile and depends entirely on clinical trial progress and regulatory decisions.
Weekly dynamics of market capitalization of the market segment - Pharma skin
As a clinical-stage biotech, Apogee Therapeutics lives in its own universe. Its weekly performance is 100% dependent on clinical trial news, not on general pharmaceutical industry trends. The chart clearly demonstrates these sharp, sector-neutral ups and downs, typical of biotechs on the cusp of breakthroughs.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Apogee Therapeutics is a clinical-stage biotech company. Its shares are buoyed by anticipation of trial results. This chart clearly demonstrates how much its performance is driven by scientific news rather than general market trends.
Market capitalization of the company, segment and market as a whole
APGE - Market capitalization of the company Apogee Therapeutics
The market capitalization chart of Apogee Therapeutics, a clinical-stage biotech, reflects investor expectations for its innovative approaches to treating inflammatory and immunological diseases. Its valuation is based not on revenue, but on the potential of its scientific developments. Sharp movements in the chart reflect the market's reaction to any clinical trial data.
APGE - Share of the company's market capitalization Apogee Therapeutics within the market segment - Pharma skin
Apogee Therapeutics is a biotech company seeking to gain market share in the treatment of inflammatory diseases such as atopic dermatitis. Its market cap is based on the potential of its long-acting antibodies that require less frequent injections.
Market capitalization of the market segment - Pharma skin
The chart below shows the overall value of the biotech sector, and Apogee Therapeutics is an interesting example, focused on immunology. The company develops long-acting antibodies. The potential of this market is enormous, and Apogee's strategy is to create more convenient and effective medications for patients with chronic diseases.
Market capitalization of all companies included in a broad market index - GURU.Markets
Apogee Therapeutics is a biotech company developing drugs to treat inflammatory and immunological diseases, such as atopic dermatitis. Its market capitalization reflects the hope for new, more effective treatments, as reflected by its weight on the chart.
Book value capitalization of the company, segment and market as a whole
APGE - Book value capitalization of the company Apogee Therapeutics
Apogee Therapeutics' foundation is its intellectual property, which covers new biologics for the treatment of inflammatory and immunological diseases. Like other early-stage biotechs, its balance sheet is based on raised capital. This graph is the financial starting point for the company, which strives to turn scientific ideas into tangible assets—approved drugs.
APGE - Share of the company's book capitalization Apogee Therapeutics within the market segment - Pharma skin
Apogee Therapeutics develops biologics, which requires advanced R&D capabilities. The chart shows the company's share of the biotech sector's real assets. These include its laboratories, where innovative drugs are created to treat dermatological and respiratory diseases.
Market segment balance sheet capitalization - Pharma skin
Apogee Therapeutics is a clinical-stage biotech company, which means it's low capital intensity. Its value lies in the intellectual property of its new antibodies, not its manufacturing facilities. Compared to the pharmaceutical sector as a whole, its "light" balance sheet is typical of companies focused on innovation rather than mass production.
Book value of all companies included in the broad market index - GURU.Markets
Apogee Therapeutics' assets represent intellectual capital focused on developing a new generation of drugs for skin and respiratory diseases. The company's balance sheet reflects the value of its research and development and clinical programs. The chart shows the amount of resources invested in a potential breakthrough in the treatment of chronic inflammation.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Apogee Therapeutics
Apogee Therapeutics is an early-stage biotech company. Its book value is primarily cash. Its market valuation is the net investor expectation of its scientific platform for treating skin diseases. The chart illustrates how news about clinical trials impacts this valuation, which is based on future potential.
Market to book capitalization ratio in a market segment - Pharma skin
Apogee Therapeutics develops drugs to treat inflammatory diseases. Like many biotechs, its value lies in its research and patents. This chart clearly shows how the market valuation, based on the potential of one or two future drugs, greatly exceeds the value of its physical assets.
Market to book capitalization ratio for the market as a whole
Apogee Therapeutics is a clinical-stage biotech company developing drugs to treat skin and respiratory diseases. Its market capitalization reflects investors' faith in the future success of its developments. This chart illustrates how market valuations can deviate from book value when it comes to breakthrough medical technologies.
Debts of the company, segment and market as a whole
APGE - Company debts Apogee Therapeutics
Apogee Therapeutics is a clinical-stage biotech company focused on immunology. For companies like these, whose revenues are far in the future, access to capital is a matter of survival. Debt financing allows them to advance their promising drugs through the expensive stages of clinical trials.
Market segment debts - Pharma skin
Apogee Therapeutics is a clinical-stage biotech company specializing in immunology. For companies like this, research funding is a key concern. Raising debt at an early stage is rare, so this chart reveals a lot about the maturity of its development and the credibility it inspires in lenders compared to traditional equity financing.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Apogee Therapeutics
Apogee Therapeutics is a clinical-stage biotech developing drugs to treat inflammatory diseases such as atopic dermatitis. This chart shows its financial position. The lack of debt and reliance on venture capital and equity capital are typical of companies whose value is based on the potential of their scientific developments.
Market segment debt to market segment book capitalization - Pharma skin
Apogee Therapeutics is a clinical-stage biotech company focused on immunology. This chart shows the level of leverage in the biopharmaceutical sector. This allows us to assess whether Apogee's financial strategy for raising capital for expensive research aligns with industry practices, where success is uncertain.
Debt to book value of all companies in the market
Apogee Therapeutics is a biotech company whose financing is largely independent of the overall state of debt markets. The chart shows the level of debt across the economy. It highlights the contrast between innovative companies, dependent on venture capital and research success, and a mature market driven by credit cycles.
P/E of the company, segment and market as a whole
P/E - Apogee Therapeutics
For Apogee Therapeutics, a biotech developing drugs for skin and respiratory diseases, this chart represents a sign of hope. Because the company is in its early stages, any earnings estimate is very high. The chart's movement reflects not current revenue, but progress in clinical trials and investor confidence in the potential of its developments.
P/E of the market segment - Pharma skin
This chart reflects the average valuation for the speculative biotech sector—a benchmark for Apogee Therapeutics. Companies in this sector often lack profitability, and the entire sector is valued based on future expectations. For investors, this is a benchmark indicating the overall level of optimism in the industry. This provides a backdrop for assessing expectations for Apogee's specific developments.
P/E of the market as a whole
Apogee Therapeutics develops drugs to treat inflammatory and immunological diseases, targeting large markets. The valuation of such companies is based on confidence in the success of clinical trials. This graph of overall risk appetite shows how willing investors are to wait. In optimistic times, they fund research; in pessimistic times, they demand rapid commercialization.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Apogee Therapeutics
Apogee Therapeutics is a biotech company focused on developing drugs for the treatment of inflammatory and immunological diseases, including skin diseases. Its valuation is based on the expected success of clinical trials. This chart shows analysts' belief in the potential of the drugs in development to become new standards of care and generate future profits.
%20P%2FE%20Apogee%20Therapeutics&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Apogee-Therapeutics&v=1772632790982 "Chart of the company's future (projected) P/E Apogee Therapeutics")
Future (projected) P/E of the market segment - Pharma skin
Apogee Therapeutics is a biotech company developing drugs to treat inflammatory and immunological diseases. Its valuation, relative to other biotechs, reflects investor expectations for its innovative antibodies. A premium valuation may indicate confidence in the potential of its platform to create best-in-class treatments.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-skin&v=1772632790997 "Future (projected) P/E graph of the market segment - Pharma skin")
Future (projected) P/E of the market as a whole
Apogee Therapeutics is a biotech company developing drugs to treat inflammatory and immunological diseases, such as atopic dermatitis. Its valuation depends on the results of clinical trials. This chart reflects the overall risk appetite of investors, which is critical for funding long-term and capital-intensive biotech research.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772632791025 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Apogee Therapeutics
Apogee Therapeutics is a biotechnology company focused on developing drugs for the treatment of inflammatory and immunological diseases, particularly skin diseases. Its financial performance, presented here, primarily reflects R&D expenses. Success in clinical trials will determine its future prospects and results.
Profit of companies in the market segment - Pharma skin
Apogee Therapeutics is a biotech company focused on developing drugs for the treatment of inflammatory and immunological diseases, particularly skin diseases. This chart shows the overall profitability of pharmaceutical companies in dermatology. It helps understand whether this niche is commercially viable, given the high competition and long R&D cycles.
Overall market profit
Apogee Therapeutics develops drugs to treat inflammatory and immunological diseases, particularly atopic dermatitis. Like most biopharmaceutical companies in the development stage, its value is determined by the potential of its drugs and their success in clinical trials, rather than by current economic cycles, as reflected in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Apogee Therapeutics
Apogee Therapeutics is a biotech company developing next-generation drugs for the treatment of skin and respiratory diseases. Its future revenue forecast is a long-term bet on the success of its clinical development. This chart shows analysts' confidence in the potential of its scientific platform and future drug commercialization.
%20profit%20of%20the%20company%20Apogee%20Therapeutics&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Apogee-Therapeutics&v=1772632791386 "Graph of future (projected) profit of the company Apogee Therapeutics")
Future (predicted) profit of companies in the market segment - Pharma skin
Apogee Therapeutics is a clinical-stage biotech company specializing in the development of antibodies for the treatment of inflammatory and immunological diseases, particularly skin diseases. This chart shows forecasts for its pharmaceutical segment. It provides investors with context for assessing the potential impact of Apogee's successful developments on the future profitability of the entire industry.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-skin&v=1772632791534 "Graph of future (predicted) profits of companies in a market segment - Pharma skin")
Future (predicted) profit of the market as a whole
Apogee Therapeutics is a biopharmaceutical company focused on treating inflammatory and immunological diseases. The overall economic backdrop, as illustrated by this chart, impacts capital availability. Optimistic forecasts facilitate the attraction of investment for the costly clinical trials that form the core of Apogee's business.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772632791579 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Apogee Therapeutics
Apogee Therapeutics is a clinical-stage biotech company with no commercial products. The market valuation, illustrated by this chart, is based solely on the belief in the future success of its developments. Investors are buying not current revenue, but the potential of its drugs to become blockbusters.
P/S market segment - Pharma skin
Apogee Therapeutics is a biotech company specializing in the development of innovative treatments for skin and respiratory diseases. This chart shows the average valuation in the pharmaceutical sector. For Apogee, it serves as an indicator of investor expectations for companies working on new drugs and their potential future revenue.
P/S of the market as a whole
Apogee Therapeutics is a biotech company focused on developing innovative drugs for the treatment of inflammatory and immunological diseases, including skin diseases. Its future revenue depends on the success of clinical trials. This chart provides investors with a general framework for assessing how the market values the biotech's potential relative to existing businesses.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Apogee Therapeutics
Apogee Therapeutics is a biotech company developing antibodies for the treatment of inflammatory and immunological diseases, including skin diseases. The company's valuation is based on expected future sales of its drugs. The chart demonstrates investors' confidence in the potential of Apogee's developments and their ability to capture a significant share of the market for the treatment of these diseases.
%20P%2FS%20Apogee%20Therapeutics&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Apogee-Therapeutics&v=1772632791774 "The graph of the company's future (projected) P/S Apogee Therapeutics")
Future (projected) P/S of the market segment - Pharma skin
Apogee Therapeutics is a biotech company specializing in the development of antibodies for the treatment of inflammatory and immunological diseases, particularly skin diseases. Its value is based on the potential of its scientific developments. This chart reflects investor expectations for Apogee's future commercial success compared to other pharmaceutical companies.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20skin&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-skin&v=1772632791778 "Future (projected) P/S market segment graph - Pharma skin")
Future (projected) P/S of the market as a whole
This chart reflects investor appetite for biotech innovation. For Apogee Therapeutics, which develops drugs to treat inflammatory and immunological diseases, it's an indicator of the investment climate. Market optimism allows the company to raise significant funds to develop a new generation of drugs with potential for multibillion-dollar sales.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772632791791 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Apogee Therapeutics
Apogee Therapeutics is a biotechnology company specializing in the development of innovative drugs for the treatment of inflammatory and immunological diseases, particularly skin diseases. This chart reflects revenue from collaborations and licensing agreements. In the future, as drugs are approved, it will reflect revenue from commercial sales.
Sales of companies in the market segment - Pharma skin
Apogee Therapeutics is a biotechnology company developing drugs for the treatment of inflammatory and immunological diseases, particularly skin diseases. This chart shows the size of the dermatology market. Apogee's innovative approaches are aimed at creating more effective and convenient treatments, reflecting industry progress in this field.
Overall market sales
Apogee Therapeutics is a biopharmaceutical company focused on treating skin and inflammatory diseases. Its development is financed by investor capital, the inflow of which depends on the overall state of the financial markets. This economic activity schedule indirectly influences investor appetite for risky but promising biotech startups.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Apogee Therapeutics
Apogee Therapeutics is a biotechnology company specializing in the development of antibodies for the treatment of inflammatory and immunological diseases, particularly skin diseases. Its future revenue depends on the success of its clinical programs. This chart reflects analysts' assessments of the company's scientific potential and the potential market size for its future drugs.
%20sales%20of%20the%20company%20Apogee%20Therapeutics&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Apogee-Therapeutics&v=1772632791925 "Schedule of future (projected) sales of the company Apogee Therapeutics")
Future (projected) sales of companies in the market segment - Pharma skin
Apogee Therapeutics is a biotechnology company focused on developing drugs for the treatment of inflammatory and immunological diseases, including skin diseases. This forecast provides insight into the expected market growth potential for the new treatments Apogee is developing.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-skin&v=1772632791948 "Schedule of future (projected) sales of companies in the market segment - Pharma skin")
Future (projected) sales of the market as a whole
Apogee Therapeutics is a biotech company specializing in the development of drugs for the treatment of inflammatory and immunological diseases, including skin diseases. Its prospects depend on the success of clinical trials. The overall economic situation, reflected in the chart, influences the investment climate in biotech and the future solvency of the market.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772632792016 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Apogee Therapeutics
Apogee Therapeutics is a biotech company focused on developing next-generation drugs for inflammatory diseases. This chart reflects its current status: all resources are focused on research. Negative values represent investments in clinical trials, which, if successful, could lead to a blockbuster launch and high profitability.
Market segment marginality - Pharma skin
Apogee Therapeutics is a biotech company developing drugs for the treatment of inflammatory and immunological diseases, particularly skin diseases. Its financial metrics reflect the R&D stage. This chart allows you to evaluate its operating cost structure compared to other biotech companies focused on developing innovative drugs.
Market marginality as a whole
Apogee Therapeutics is a biotechnology company specializing in the development of drugs for the treatment of immunological diseases, particularly skin diseases. This overall market profitability figure is of secondary importance to the company. Its future profitability depends solely on the success of clinical trials and the ability to develop a marketable drug that will find its niche.
Employees in the company, segment and market as a whole
Number of employees in the company Apogee Therapeutics
Apogee Therapeutics is a biotech company focused on developing innovative treatments for inflammatory and immunological diseases. This chart shows the growing team of scientists and clinicians advancing new drugs through the development stages. Their number is an indicator of R&D progress.
Share of the company's employees Apogee Therapeutics within the market segment - Pharma skin
Apogee Therapeutics is a biotechnology company focused on developing cutting-edge treatments for skin and respiratory diseases. This chart shows the percentage of leading immunologist and clinical scientists Apogee attracts in its niche therapeutic area. It reflects the concentration of scientific talent needed to create innovative biologics.
Number of employees in the market segment - Pharma skin
Apogee Therapeutics is a biotech company developing innovative treatments for inflammatory and immunological diseases, with a particular focus on dermatology and respiratory diseases. This chart reflects employment in specialty pharmaceuticals, showing how scientific breakthroughs in understanding the immune system are leading to new therapies and jobs.
Number of employees in the market as a whole
Apogee Therapeutics is a biotechnology company focused on developing drugs for the treatment of inflammatory and immunological diseases. This sector creates jobs for highly qualified scientists and clinicians. Their success is an investment in the nation's health and in the intellectual capital that will shape the economy of the future, going beyond mere employment.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Apogee Therapeutics (APGE)
Apogee Therapeutics is a clinical-stage biopharmaceutical company focused on immunology. This chart is a classic example of a biotech startup. The astronomical market capitalization per employee reflects not current revenue, but rather investors' faith in the scientific platform developed by a small team of scientists. The market is assessing the potential of future drugs.
%20of%20the%20company%20Apogee%20Therapeutics%20(APGE)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Apogee-Therapeutics-APGE&v=1772632792174 "Chart of market capitalization per employee (in thousands of dollars) of the company Apogee Therapeutics (APGE)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma skin
Apogee Therapeutics is a clinical-stage biotech developing antibodies for the treatment of inflammatory and immunological diseases, such as atopic dermatitis. This chart shows the industry average cost per employee. It helps estimate the market premium for their scientific platform and drug candidates, based on their small staff of scientists.
%20by%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-skin&v=1772632792179 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma skin")
Market capitalization per employee (in thousands of dollars) for the overall market
Apogee Therapeutics is a biotech company focused on developing drugs for inflammatory and immunological diseases. This chart shows the average market value assigned to each employee. It helps understand the high valuation of scientific potential and intellectual property.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772632792229 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Apogee Therapeutics (APGE)
Apogee Therapeutics is a clinical-stage biotech company focused on immunological diseases (e.g., skin diseases). Like other R&D companies, this graph shows the loss per employee. It reflects the intensity of investment in the scientists working on developing potential blockbusters.
%20Chart%20Apogee%20Therapeutics%20(APGE)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Apogee-Therapeutics-APGE&v=1772632792296 "Company Profit Per Employee (in thousands of dollars) Chart Apogee Therapeutics (APGE)")
Profit per employee (in thousands of dollars) in the market segment - Pharma skin
Apogee Therapeutics (APGE) is an R&D biotech company (immunology, dermatology). This chart shows the benchmark for "Pharma" (R&D). The average profit per employee in this sector (venture R&D) is *negative*. This benchmark reflects the "burning" of money in the hopes of one or two mega-successes. The entire sector is an R&D race, spending billions on elite scientists.
%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-skin&v=1772632792370 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma skin")
Profit per employee (in thousands of dollars) for the market as a whole
Apogee Therapeutics is a clinical-stage biotech company specializing in immunology and inflammatory diseases (such as skin). Like other R&D biopharmaceuticals, they are not profitable. This chart shows the loss per employee—the "burn rate" of capital spent on breakthrough research and clinical trials.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772632792406 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Apogee Therapeutics (APGE)
Apogee Therapeutics is a biotech company focused on immunology and skin disease treatment. For a clinical-stage biotech, this graph is a promise of future revenue. It reflects the potential for a successful drug to generate colossal revenue with the help of a small commercial team.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Apogee-Therapeutics-APGE&v=1772632792433 "Sales chart per company employee Apogee Therapeutics (APGE)")
Sales per employee in the market segment - Pharma skin
Apogee Therapeutics is a clinical-stage biotech company focused on treating inflammatory diseases, including dermatitis. Revenue is not yet available. This chart shows the average revenue per employee in the segment, which serves as a benchmark for commercial pharmaceutical companies. It provides context for assessing the effectiveness of Apogee's staff.
Sales per employee for the market as a whole
Apogee Therapeutics is a clinical-stage biotech company focused on immunology and dermatology. The company has no commercial products and, therefore, no revenue. This metric is currently irrelevant. The company's entire value lies in the potential of its R&D team to create in-demand drugs in the future.
Short shares by company, segment and market as a whole
Shares shorted by company Apogee Therapeutics (APGE)
Apogee Therapeutics is a biotech company developing drugs to treat inflammatory and immune diseases, such as skin conditions. The company's shares, which are in early research, are highly volatile. This chart shows the volume of bearish bets by those who doubt the success of clinical trials or believe the market's initial optimism is overblown.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Apogee-Therapeutics-APGE&v=1772632792467 "Short Shares Chart for the Company Apogee Therapeutics (APGE)")
Shares shorted by market segment - Pharma skin
Apogee Therapeutics is a biotech company developing drugs for the treatment of inflammatory and immunological diseases, such as atopic dermatitis, with a focus on rare injectables. This chart shows the overall short position in the immunology biotech sector. Its rise signals investor doubts about the clinical success or commercial potential of new drugs in this niche.
Shares shorted by the overall market
Apogee (APGE) is a clinical-stage biotech (immunology). This indicator (`Short_All`) is a mirror of market fear. When it rises, investors panic and dump risk, especially unprofitable biotechs. This pessimism, visible on the chart, deprives APGE of access to the capital needed for expensive trials.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Apogee Therapeutics (APGE)
Apogee Therapeutics (APGE) is a clinical-stage biotech focused on developing innovative treatments for inflammatory and immunological diseases, such as atopic dermatitis. This chart measures hype. Like many biotechs, it shows "overheated" (above 70) during positive research data or "oversold" (below 30) during periods of no news.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Apogee-Therapeutics-APGE&v=1772632792521 "RSI 14 indicator chart for the company's stock Apogee Therapeutics (APGE)")
RSI 14 Market Segment - Pharma skin
Apogee Therapeutics (APGE) is a biotech company developing drugs (antibodies) for the treatment of inflammatory and immunological diseases, such as atopic dermatitis. This chart measures the pulse of the Pharma/Immunology sector. It helps distinguish Apogee's clinical trial successes from the overall "overheated" or "oversold" sentiment across the biotech sector.
RSI 14 for the overall market
Apogee Therapeutics (APGE) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic poses the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast APGE (Apogee Therapeutics)
Apogee Therapeutics is a biotech company developing next-generation antibodies for the treatment of inflammatory and immune diseases, such as atopic dermatitis, with the goal of extending dosing intervals. This chart shows the average analyst price target, reflecting their expectations for clinical data.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-APGE-Apogee-Therapeutics&v=1772632792648 "A chart showing analyst consensus forecasts for the expected stock price. APGE (Apogee Therapeutics)")
The difference between the consensus estimate and the actual stock price APGE (Apogee Therapeutics)
Apogee Therapeutics (APGE) is a biotech company developing next-generation antibodies to treat inflammatory and immunological diseases, such as atopic dermatitis. This chart is a barometer of hope. It measures the gap between the price and the consensus target, reflecting the high potential analysts see in their R&D pipeline.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-APGE-Apogee-Therapeutics&v=1772632792676 "A chart showing the difference between the consensus forecast and the actual stock price. APGE (Apogee Therapeutics)")
Analyst consensus forecast for stock prices by market segment - Pharma skin
Apogee Therapeutics is a biotech company developing biologic drugs for the treatment of immunological and inflammatory skin diseases (atopic dermatitis). This chart shows general expectations for the dermatology sector. It reflects whether experts believe new drugs will be competitive in a crowded market.
Analysts' consensus forecast for the overall market share price
Apogee Therapeutics (APGE) is a clinical-stage biotech focused on immunology (skin diseases, asthma). This is a risky R&D story. This chart of overall market sentiment is important. Optimism = the market is willing to burn money funding unprofitable biotechs with high potential. Pessimism = risk aversion, and capital for R&D dries up.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Apogee Therapeutics
Apogee Therapeutics is a clinical-stage biotech company focused on developing innovative therapeutics (antibodies) for the treatment of immunological and inflammatory diseases, including skin diseases. This chart represents an assessment of their science. Its dynamics depend entirely on their progress in clinical trials and the market's confidence in their R&D platform.
AKIMA Market Segment Index - Pharma skin
Apogee Therapeutics (APGE) is a clinical-stage biotech focused on immunology; the company is developing next-generation biologics (antibodies) for the treatment of atopic dermatitis and asthma. This summary metric evaluates R&D. The graph shows the segment average. This benchmark: how does Apogee's competitive (but enormous) R&D focus differentiate it from the average pharma company?
The AKIM Index for the overall market
Apogee Therapeutics is a biotech company developing biologic drugs for the treatment of immunological and inflammatory diseases (dermatitis, asthma). This chart, reflecting the market average, provides a macro backdrop. It helps assess how this innovative scientific company, competing in a large market, stacks up against overall economic trends.
